The staff showed symptoms of infection one after another. The quality control department of Daye peak arranged to tide over the difficulties as a whole.
Release time:
2023-01-12
With the release of epidemic control, 2022 12# May 14 afternoon, Daye Peak Cement Company analysis group an employee of a sudden high fever, the next day at home to rest, and then one after another employees have fever and cough and other symptoms of infection. The turning point of the epidemic situation of
has had a certain impact on the work. At most, the employees of 4 have a rest, and the employees of 3 have a rest, and the employees of 3 have a rest. Due to the relatively compact staffing in the past two years, in order to ensure that the normal inspection work of the department will not be affected, the office of daye peak quality control department immediately started emergency measures, and all personnel will be arranged by the office as a whole to make the best use of their talents. Except for important positions such as molding, which cannot be replaced, other positions in the material inspection team are rotated by the analysis team and site shift personnel, and the analysis team ensures that one person is on the job. Since the control group has only one person per shift, in order to reduce the unnecessary movement of personnel, the department requires other personnel not to be moved and gathered by the control group for non-work needs, and to protect the control group personnel, so all the work of the department is carried out in an orderly manner. The quality control department was able to deal with this emergency calmly, mainly due to the job exchange and learning work that has been carried out at ordinary times, not limited to a certain post and type of work.
2022
7, the quality control department began to analyze and study the intermodulation of material inspection posts. while ensuring the completion of this post, each team selected two employees to study. Although they are all old employees, they have only worked in this position all the time. They also have a little knowledge of the work of other teams and groups. They have to learn everything from scratch. Analysts learn from mold removal, mold wiping, mold assembly and then to mold breaking. Material inspectors slowly begin to understand from cement loss on ignition, sulfur trioxide and bituminous coal analysis to clinker analysis. All employees who exchange positions hold the mentality of apprentices, asking questions if they don't understand or not, learning while doing. They are both apprentices and masters, learning from each other and guiding each other. This emergency, through the overall arrangement of personnel, with the joint efforts of everyone, not only successfully overcome the difficulties, but also further improved the cohesion and centripetal force of the department. (Liu Su-ming)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page